-transparent.png){kind=logo}
Newborns and infants up to the age of 1.5-2 years of age are unable to produce antibodies to bacterial capsular polysaccharides. As a consequence, children up to the age of 2 years have an increased susceptibility for infections with encapsulated bacteria. Capsular polysaccharides are classified as so-called T cell independent type 2 antigens and induce IgG2 antibodies. The mechanism of B lymphocyte activation by polysaccharides differs from that of protein antigens and involves co-stimulation by CD21 (type 2 complement receptor). Reduced expression of CD21 on neonatal B lymphocytes can explain unresponsiveness to polysaccharides. Polysaccharide protein conjugates have the ability to overcome unresponsiveness to polysaccharides early in life. The response induced is predominant IgGl.
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 2014,
Human vaccines & immunotherapeutics,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 2010,
Pediatric nursing,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 2017,
Genome medicine,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 2018,
PloS one,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
April 1990,
Pediatrics,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 1998,
Vaccine,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
January 2015,
PloS one,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
September 1989,
Seminars in immunology,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
November 1995,
Pediatrics,
G T Rijkers, and
E A Sanders, and
M A Breukels, and
B J Zegers
February 1989,
Immunological reviews,
